
Progress in Pediatric Cardiology, Journal Year: 2024, Volume and Issue: unknown, P. 101775 - 101775
Published: Dec. 1, 2024
Language: Английский
Progress in Pediatric Cardiology, Journal Year: 2024, Volume and Issue: unknown, P. 101775 - 101775
Published: Dec. 1, 2024
Language: Английский
Progress in Cardiovascular Diseases, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
1Progress in Cardiovascular Diseases, Journal Year: 2024, Volume and Issue: 86, P. 54 - 61
Published: Aug. 25, 2024
The knowledge on the prevalence of elevated lipoprotein(a) (Lp(a)), patients' characteristics, and nongenetic risk factors is scarce in some regions including Poland, largest Central Eastern European country. Thus, we aimed to present results from Lp(a) registry established Poland's 2nd largest, supra-regional hospital - Polish Mother's Memorial Hospital Research Institute (PMMHRI).
Language: Английский
Citations
4Progress in Cardiovascular Diseases, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
0Russian Cardiology Bulletin, Journal Year: 2025, Volume and Issue: 20(1), P. 39 - 39
Published: April 14, 2025
Objective. Serum lipoprotein(a) (Lp(a))>50 mg/dl is associated with higher risk of cardiovascular diseases and complications. The aim this study was to assess the prevalence elevated Lp(a) in patients acute myocardial infarction (MI) various regions Russian Federation (RF), as well target level low-density lipoprotein cholesterol (LDL cholesterol) these patients. Material methods. REGION–IM (Russian Registry Acute Myocardial Infarction) a multiple-center prospective observational study. follow-up included 3 stages: hospital-stay, 6 12 months after inclusion register. Demographic anamnestic data, information about MI were entered into registration card. analyzed 1.623 (22%) from 40 Federation. There 1.173 (72%) men 450 (28%) women aged 60 years (range 30—94). Results. Mean serum 12.4 2 — 722.2). This value significantly (15.5 versus 10.8 mg/dl, p<0.05) STEMI (12.9 p<0.05). >50 recorded 414 (26%) patients, 50—100 12.9%, 101—180 2.9%, > 180 10.3% Conclusion. 50 every fourth patient while extreme elevation (>180 mg/dl) tenth Screening at least once lifetime will allow determining category extremely high complications including those LDL-C.
Language: Английский
Citations
0Frontiers in Cardiovascular Medicine, Journal Year: 2024, Volume and Issue: 11
Published: Nov. 22, 2024
Background Following the identification of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, research in this area has experienced significant growth. However, a thorough bibliometric analysis burgeoning field remains conspicuously absent. The current study aims to delineate hotspots and anticipate future trends on PCSK9 inhibitors employing analysis. Methods A systematic search was conducted Web Science Core Collection (WoSCC) identify scholarly articles reviews pertaining yielding 1,812 documents. Data extraction followed by visualization using Excel, VOSviewer, CiteSpace software. Results total publications were included final Ray, KK from UK most prolific author, Pordy, R USA. USA led publication output [number (Np):776] number citations without self-citations (Nc) at 34,289, as well an H-index 93. “Cardiovascular System Cardiology” emerged predominant subject area. Amgen Journal Clinical Lipidology identified active institution journal, respectively. Keywords such “lipoprotein(a),” “bempedoic acid,” “percutaneous coronary intervention,” “inclisiran,” “peripheral artery disease,” “mortality,” “endothelial dysfunction” are gaining prominence field. Conclusion is experiencing sustained growth trajectory. exerts considerable influence area, with expected feature more groundbreaking studies. Research “lipoprotein(a)”, acid”, intervention”, disease”, poised become focal points investigation.
Language: Английский
Citations
0Progress in Pediatric Cardiology, Journal Year: 2024, Volume and Issue: unknown, P. 101775 - 101775
Published: Dec. 1, 2024
Language: Английский
Citations
0